Skip to main content
Top
Published in: Journal of Clinical Immunology 2/2009

01-03-2009

First Report of Clinical, Functional, and Molecular Investigation of Chronic Granulomatous Disease in Nine Jordanian Families

Authors: Faris G. Bakri, Cécile Martel, Najwa Khuri-Bulos, Azmi Mahafzah, Mohammad S. El-Khateeb, Adel M. Al-Wahadneh, Wail A. Hayajneh, Hanan A. Hamamy, Elisabeth Maquet, Michelle Molin, Marie José Stasia

Published in: Journal of Clinical Immunology | Issue 2/2009

Login to get access

Abstract

Introduction

Chronic granulomatous disease is a rare inherited immunodeficiency syndrome caused by mutations in four genes encoding essential nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex components.

Material and methods

Clinical, functional, and molecular investigations were conducted in 15 Jordanian CGD patients from nine families.

Results and Discussion

Fourteen patients were children of consanguineous parents and suffered from autosomal recessive (AR) CGD forms with mutations in the CYBA, NCF1, and NCF2 genes encoding p22phox, p47phox, and p67phox proteins, except for one patient in whom the mutation’s location was not found. One patient had an extremely rare X+CGD subtype resulting from a novel missense mutation (G1234C) in exon 10 of CYBB. We found a genetic heterogeneity in the Jordanian families with a high frequency of rare ARCGD, probably because consanguineous marriages are common in Jordan. No clear correlation between the severity of the clinical symptoms and the CGD types could be established.
Literature
2.
go back to reference Stasia MJ, Li XJ. Genetic and immunopathology of chronic granulomatous disease. Semin Immunopathol 2008;30(3):209–35.PubMedCrossRef Stasia MJ, Li XJ. Genetic and immunopathology of chronic granulomatous disease. Semin Immunopathol 2008;30(3):209–35.PubMedCrossRef
5.
go back to reference Azuma H, Oomi K, Sasak I, Kawabata T, Sakaino S, Koyano T, et al. A new mutation in exon 12 of the gp91-phox gene leading to cytochrome b-positive X-linked chronic granulomatous disease. Blood 1995;85:3274–7.PubMed Azuma H, Oomi K, Sasak I, Kawabata T, Sakaino S, Koyano T, et al. A new mutation in exon 12 of the gp91-phox gene leading to cytochrome b-positive X-linked chronic granulomatous disease. Blood 1995;85:3274–7.PubMed
8.
go back to reference Tsuda M, Kaneda M, Sakiyama T, Inana I, Owada M, Kiryu C, et al. A novel mutation at a probable heme-binding ligand in neutrophil cytochrome b558 in atypical X-linked chronic granulomatous disease. Hum Genet 1998;103:377–81. doi:10.1007/s004390050836.PubMedCrossRef Tsuda M, Kaneda M, Sakiyama T, Inana I, Owada M, Kiryu C, et al. A novel mutation at a probable heme-binding ligand in neutrophil cytochrome b558 in atypical X-linked chronic granulomatous disease. Hum Genet 1998;103:377–81. doi:10.​1007/​s004390050836.PubMedCrossRef
9.
go back to reference Yu L, Cross AR, Zhen L, Dinauer MC. Functional analysis of NADPH oxidase in granulocytic cells expressing a Δ488-497 pg91-phox deletion mutant. Blood 1999;94:2497–504.PubMed Yu L, Cross AR, Zhen L, Dinauer MC. Functional analysis of NADPH oxidase in granulocytic cells expressing a Δ488-497 pg91-phox deletion mutant. Blood 1999;94:2497–504.PubMed
10.
go back to reference Leusen JH, Meischl C, Eppink MHM, Hilarius PM, de Boer M, Weening RS, et al. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly. Blood 2000;95:666–73.PubMed Leusen JH, Meischl C, Eppink MHM, Hilarius PM, de Boer M, Weening RS, et al. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly. Blood 2000;95:666–73.PubMed
11.
go back to reference Stasia MJ, Lardy B, Maturana A, Rousseau P, Martel C, Bordigoni P, et al. Molecular and functional characterization of a new X-linked chronic granulomatous disease variant (X91+) case with a double missense mutation in the gp91-phox-cytosolique C-terminal tail. Biochim Biophys Acta 2002;1586:316–30.PubMed Stasia MJ, Lardy B, Maturana A, Rousseau P, Martel C, Bordigoni P, et al. Molecular and functional characterization of a new X-linked chronic granulomatous disease variant (X91+) case with a double missense mutation in the gp91-phox-cytosolique C-terminal tail. Biochim Biophys Acta 2002;1586:316–30.PubMed
12.
go back to reference Bionda C, Li XJ, van Bruggen R, Eppink M, Roos D, Morel F, et al. Functional analysis of two-amino acid substitution in gp91phox in a patient with X-linked flavocytochrome-b 558-positive chronic granulomatous disease by means of transgenic PLB-985 cells. Hum Genet 2004;115:418–27. doi:10.1007/s00439-004-1173-z.PubMedCrossRef Bionda C, Li XJ, van Bruggen R, Eppink M, Roos D, Morel F, et al. Functional analysis of two-amino acid substitution in gp91phox in a patient with X-linked flavocytochrome-b 558-positive chronic granulomatous disease by means of transgenic PLB-985 cells. Hum Genet 2004;115:418–27. doi:10.​1007/​s00439-004-1173-z.PubMedCrossRef
13.
go back to reference Li XJ, Fieschi F, Paclet MH, Grunwald D, Campion Y, Gaudin P, et al. Leu505 of Nox2 is crucial for optimal p67phox-dependent activation of the flavocytochrome b558 during phagocytic NADPH oxidase assembly. J Leukoc Biol 2007;81:238–49. doi:10.1189/jlb.0905541.PubMedCrossRef Li XJ, Fieschi F, Paclet MH, Grunwald D, Campion Y, Gaudin P, et al. Leu505 of Nox2 is crucial for optimal p67phox-dependent activation of the flavocytochrome b558 during phagocytic NADPH oxidase assembly. J Leukoc Biol 2007;81:238–49. doi:10.​1189/​jlb.​0905541.PubMedCrossRef
14.
go back to reference Stasia MJ. The X+ chronic granulomatous disease as a fabulous model to study the NADPH oxidase complex activation. Med Sci (Paris) 2007;23:526–32. (Review). Stasia MJ. The X+ chronic granulomatous disease as a fabulous model to study the NADPH oxidase complex activation. Med Sci (Paris) 2007;23:526–32. (Review).
15.
go back to reference Roos D, De Boer M, Kuribayashi F, Meischl C, Weening RS, Segal AW, et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 1996;87:1663–81.PubMed Roos D, De Boer M, Kuribayashi F, Meischl C, Weening RS, Segal AW, et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 1996;87:1663–81.PubMed
16.
go back to reference Rae J, Newburger PE, Dinauer MC. X-linked chronic granulomatous disease:mutations in the CYBB gene encoding the gp91-phox component of respiratory burst oxidase. Am J Hum Genet 1998;62:1320–31. doi:10.1086/301874.PubMedCrossRef Rae J, Newburger PE, Dinauer MC. X-linked chronic granulomatous disease:mutations in the CYBB gene encoding the gp91-phox component of respiratory burst oxidase. Am J Hum Genet 1998;62:1320–31. doi:10.​1086/​301874.PubMedCrossRef
17.
go back to reference Noack D, Rae J, Cross AR, Ellis BA, Newburger PE, Curnutte JT, et al. Autosomal recessive chronic granulomatous disease caused by defects in NCF-1, the gene encoding the phagocyte p47-phox: mutations not arising in the NCF-1 pseudogenes. Blood 2001;97:305–11. doi:10.1182/blood.V97.1.305.PubMedCrossRef Noack D, Rae J, Cross AR, Ellis BA, Newburger PE, Curnutte JT, et al. Autosomal recessive chronic granulomatous disease caused by defects in NCF-1, the gene encoding the phagocyte p47-phox: mutations not arising in the NCF-1 pseudogenes. Blood 2001;97:305–11. doi:10.​1182/​blood.​V97.​1.​305.PubMedCrossRef
18.
go back to reference Roos D, de Boer M, Köker MY, Dekker J, Singh-Gupta V, Ahlin A, et al. Chronic granulomatous disease caused by mutations other than the common GT deletion in NCF1, the gene encoding the p47phox component of the phagocyte NADPH oxidase. Hum Mutat 1996;27:1218–29. doi:10.1002/humu.20413.CrossRef Roos D, de Boer M, Köker MY, Dekker J, Singh-Gupta V, Ahlin A, et al. Chronic granulomatous disease caused by mutations other than the common GT deletion in NCF1, the gene encoding the p47phox component of the phagocyte NADPH oxidase. Hum Mutat 1996;27:1218–29. doi:10.​1002/​humu.​20413.CrossRef
20.
go back to reference Cohen-Tanugi L, Morel F, Pilloud-Dagher MC, Seigneurin JM, François P, Bost M, et al. Activation of O2 - generating oxidase in heterologous cell-free system derived from Epstein-Barr-virus-transformed human B lymphocytes and bovine neutrophils. Eur J Biochem. 1991;202:649–55. doi:10.1111/j.1432-1033.1991.tb16419.x.PubMedCrossRef Cohen-Tanugi L, Morel F, Pilloud-Dagher MC, Seigneurin JM, François P, Bost M, et al. Activation of O2 - generating oxidase in heterologous cell-free system derived from Epstein-Barr-virus-transformed human B lymphocytes and bovine neutrophils. Eur J Biochem. 1991;202:649–55. doi:10.​1111/​j.​1432-1033.​1991.​tb16419.​x.PubMedCrossRef
22.
go back to reference Batot G, Paclet MH, Doussière J, Vergnaud S, Martel C, Vignais PV, et al. Biochemical and immunochemical properties of B lymphocyte cytochrome b 558 . Biochim Biophys Acta. 1998;1406:188–202.PubMed Batot G, Paclet MH, Doussière J, Vergnaud S, Martel C, Vignais PV, et al. Biochemical and immunochemical properties of B lymphocyte cytochrome b 558 . Biochim Biophys Acta. 1998;1406:188–202.PubMed
26.
go back to reference Verhoeven AJ, Bolscher GJM, Meerhof L, van Zwieten R, Keijer J, Weening RS, et al. Characterization of two monoclonal antibodies against cytochrome b 558 of human neutrophils. Blood 1989;73:1686–94.PubMed Verhoeven AJ, Bolscher GJM, Meerhof L, van Zwieten R, Keijer J, Weening RS, et al. Characterization of two monoclonal antibodies against cytochrome b 558 of human neutrophils. Blood 1989;73:1686–94.PubMed
31.
go back to reference de Boer M, Singh V, Dekker J, Di Rocco M, Goldblatt D, Roos D. Prenatal diagnosis in two families with autosomal, p47phox-deficient chronic granulomatous disease due to a novel point mutation in NCF1. Prenat Diagn. 2002;22:235–40. doi:10.1002/pd.296.PubMedCrossRef de Boer M, Singh V, Dekker J, Di Rocco M, Goldblatt D, Roos D. Prenatal diagnosis in two families with autosomal, p47phox-deficient chronic granulomatous disease due to a novel point mutation in NCF1. Prenat Diagn. 2002;22:235–40. doi:10.​1002/​pd.​296.PubMedCrossRef
32.
go back to reference Patiño PJ, Rae J, Noack D, Erickson R, Ding J, de Olarte DG, et al. Molecular characterization of autosomal recessive chronic granulomatous disease caused by a defect of the nicotinamide adenine dinucleotide phosphate (reduced form) oxidase component p67-phox. Blood 1999;94:2505–14.PubMed Patiño PJ, Rae J, Noack D, Erickson R, Ding J, de Olarte DG, et al. Molecular characterization of autosomal recessive chronic granulomatous disease caused by a defect of the nicotinamide adenine dinucleotide phosphate (reduced form) oxidase component p67-phox. Blood 1999;94:2505–14.PubMed
33.
go back to reference El Kares R, Barbouche MR, Elloumi-Zghal H, Bejaoui M, Chemli J, Mellouli F, et al. Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia. J Hum Genet. 2006;51:887–95. doi:10.1007/s10038-006-0039-8.PubMedCrossRef El Kares R, Barbouche MR, Elloumi-Zghal H, Bejaoui M, Chemli J, Mellouli F, et al. Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia. J Hum Genet. 2006;51:887–95. doi:10.​1007/​s10038-006-0039-8.PubMedCrossRef
34.
go back to reference Ishibashi F, Nunoi H, Endo F, Matsuda I, Kanegasaki F. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency. Hum Genet. 2000;106:473–81. doi:10.1007/s004390000288.PubMedCrossRef Ishibashi F, Nunoi H, Endo F, Matsuda I, Kanegasaki F. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency. Hum Genet. 2000;106:473–81. doi:10.​1007/​s004390000288.PubMedCrossRef
35.
go back to reference Cross AR, Noack D, Rae J, Curnutte JT, Heyworth PG. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (first update). Blood Cells Mol Dis. 2000;26:561–5. doi:10.1006/bcmd.2000.0333.PubMedCrossRef Cross AR, Noack D, Rae J, Curnutte JT, Heyworth PG. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (first update). Blood Cells Mol Dis. 2000;26:561–5. doi:10.​1006/​bcmd.​2000.​0333.PubMedCrossRef
37.
go back to reference Hamamy HA, Masri AT, Al-Hadidy AM, Ajlouni KM. Consanguinity and genetic disorders. Profile from Jordan. Saudi Med J. 2007;28:1015–7.PubMed Hamamy HA, Masri AT, Al-Hadidy AM, Ajlouni KM. Consanguinity and genetic disorders. Profile from Jordan. Saudi Med J. 2007;28:1015–7.PubMed
39.
40.
go back to reference Leusen JH, Bolscher BG, Hilarius PM, Weening RS, Kaulfersch W, Seger RA, et al. 156Pro–>Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Exp Med. 1996;180:2329–34. doi:10.1084/jem.180.6.2329.CrossRef Leusen JH, Bolscher BG, Hilarius PM, Weening RS, Kaulfersch W, Seger RA, et al. 156Pro–>Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Exp Med. 1996;180:2329–34. doi:10.​1084/​jem.​180.​6.​2329.CrossRef
41.
go back to reference Dinauer MC, Pierce EA, Bruns GAP, Curnutte JT, Orkin SH. Human neutrophil cytochrome b light chain (p22phox): gene structure, chromosomal localization and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest. 1990;86:1729–37. doi:10.1172/JCI114898.PubMedCrossRef Dinauer MC, Pierce EA, Bruns GAP, Curnutte JT, Orkin SH. Human neutrophil cytochrome b light chain (p22phox): gene structure, chromosomal localization and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest. 1990;86:1729–37. doi:10.​1172/​JCI114898.PubMedCrossRef
43.
go back to reference Hussain N, Feld JJ, Kleiner DE, Hoofnagle JH, Garcia-Eulate R, Ahlawat S, et al. Hepatic abnormalities in patients with chronic granulomatous disease. Hepatology 2007;45:675–83. doi:10.1002/hep.21524.PubMedCrossRef Hussain N, Feld JJ, Kleiner DE, Hoofnagle JH, Garcia-Eulate R, Ahlawat S, et al. Hepatic abnormalities in patients with chronic granulomatous disease. Hepatology 2007;45:675–83. doi:10.​1002/​hep.​21524.PubMedCrossRef
44.
go back to reference Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, et al. IPINET. Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. Clin Immunol. 2008;126:155–64. doi:10.1016/j.clim.2007.09.008.PubMedCrossRef Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, et al. IPINET. Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. Clin Immunol. 2008;126:155–64. doi:10.​1016/​j.​clim.​2007.​09.​008.PubMedCrossRef
45.
go back to reference Casimir CM, Bu-Ghanim HN, Rodaway AR, Bentley DL, Rowe P, Segal AW. Autosomal recessive chronic granulomatous disease caused by deletion at a dinucleotide repeat. Proc Natl Acad Sci USA. 1991;88:2753–57.PubMedCrossRef Casimir CM, Bu-Ghanim HN, Rodaway AR, Bentley DL, Rowe P, Segal AW. Autosomal recessive chronic granulomatous disease caused by deletion at a dinucleotide repeat. Proc Natl Acad Sci USA. 1991;88:2753–57.PubMedCrossRef
Metadata
Title
First Report of Clinical, Functional, and Molecular Investigation of Chronic Granulomatous Disease in Nine Jordanian Families
Authors
Faris G. Bakri
Cécile Martel
Najwa Khuri-Bulos
Azmi Mahafzah
Mohammad S. El-Khateeb
Adel M. Al-Wahadneh
Wail A. Hayajneh
Hanan A. Hamamy
Elisabeth Maquet
Michelle Molin
Marie José Stasia
Publication date
01-03-2009
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 2/2009
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-008-9243-y

Other articles of this Issue 2/2009

Journal of Clinical Immunology 2/2009 Go to the issue